TABLE 3.
Toxin | Bmax (fmol/μg) | K′D (nM) | Hill coefficient |
---|---|---|---|
4BRA | 13.1 ± 0.5 | 6.9 ± 2.7 | 4.8 ± 0.8 |
4BL3PAT | 9.3 ± 0.4 | 0.9 ± 0.2 | 2.8 ± 0.5 |
4BL3PAT* | 18.3 ± 1.6 | 2.6 ± 0.5 | 2.3 ± 0.4 |
Each binding condition was conducted with 250 M excess homologous toxin added to reduce nonspecific binding, with the exception that 4BL3PAT* was conducted with 250 M excess 4BRA.